Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cosmc is an X-linked inflammatory bowel disease risk gene that spatially regulates gut microbiota and contributes to sex-specific risk.
Kudelka MR, Hinrichs BH, Darby T, Moreno CS, Nishio H, Cutler CE, Wang J, Wu H, Zeng J, Wang Y, Ju T, Stowell SR, Nusrat A, Jones RM, Neish AS, Cummings RD. Kudelka MR, et al. Among authors: hinrichs bh. Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14787-14792. doi: 10.1073/pnas.1612158114. Epub 2016 Dec 7. Proc Natl Acad Sci U S A. 2016. PMID: 27930307 Free PMC article.
Serum Amyloid A1 Is an Epithelial Prorestitutive Factor.
Hinrichs BH, Matthews JD, Siuda D, O'Leary MN, Wolfarth AA, Saeedi BJ, Nusrat A, Neish AS. Hinrichs BH, et al. Am J Pathol. 2018 Apr;188(4):937-949. doi: 10.1016/j.ajpath.2017.12.013. Epub 2018 Jan 31. Am J Pathol. 2018. PMID: 29366677 Free PMC article.
Proteomic analysis of microbial induced redox-dependent intestinal signaling.
Matthews JD, Reedy AR, Wu H, Hinrichs BH, Darby TM, Addis C, Robinson BS, Go YM, Jones DP, Jones RM, Neish AS. Matthews JD, et al. Among authors: hinrichs bh. Redox Biol. 2019 Jan;20:526-532. doi: 10.1016/j.redox.2018.11.011. Epub 2018 Nov 22. Redox Biol. 2019. PMID: 30508697 Free PMC article.
Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck.
Leddon JL, Gulati S, Haque S, Allen C, Palackdharry S, Mathews M, Kurtzweil N, Riaz MK, Takiar V, Nagasaka M, Patil Y, Zender C, Tang A, Cervenka B, McGrath J, Korn WM, Hinrichs BH, Jandarov R, Harun N, Sukari A, Wise-Draper TM. Leddon JL, et al. Among authors: hinrichs bh. Clin Cancer Res. 2022 Aug 15;28(16):3464-3472. doi: 10.1158/1078-0432.CCR-21-4554. Clin Cancer Res. 2022. PMID: 35653116 Free PMC article. Clinical Trial.
18 results